Header Logo

Christopher Coogan

Concepts (84)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urology
4
2019
8
1.360
Why?
Malpractice
3
2015
6
1.220
Why?
Clinical Competence
2
2015
96
0.830
Why?
Kidney Neoplasms
4
2018
41
0.620
Why?
Carcinoma, Renal Cell
3
2018
24
0.600
Why?
Prostatic Neoplasms
4
2019
36
0.490
Why?
Prostate
3
2019
15
0.390
Why?
Nephrons
1
2012
3
0.370
Why?
Insurance, Liability
1
2010
1
0.320
Why?
Prostatectomy
3
2005
12
0.320
Why?
Penile Neoplasms
1
2008
1
0.280
Why?
Lymph Node Excision
1
2008
15
0.270
Why?
Nephrectomy
2
2018
17
0.270
Why?
Carcinoma, Squamous Cell
1
2008
70
0.260
Why?
Humans
13
2019
12240
0.240
Why?
Adenocarcinoma
2
2003
61
0.230
Why?
Biopsy, Needle
1
2005
56
0.220
Why?
Male
10
2019
6815
0.210
Why?
Prostatic Intraepithelial Neoplasia
1
2003
1
0.190
Why?
Prostatic Hyperplasia
1
2003
7
0.190
Why?
Glycoproteins
1
2003
30
0.190
Why?
Genital Neoplasms, Male
1
2002
1
0.190
Why?
Seminal Vesicles
1
2002
1
0.190
Why?
Neurilemmoma
1
2002
5
0.190
Why?
Middle Aged
8
2018
4043
0.180
Why?
United States
3
2015
989
0.170
Why?
Magnetic Resonance Imaging
2
2019
464
0.170
Why?
Image-Guided Biopsy
1
2019
20
0.150
Why?
Ultrasonography
1
2019
152
0.140
Why?
Early Detection of Cancer
1
2018
59
0.130
Why?
Aged
5
2018
4000
0.130
Why?
Renal Veins
1
2017
2
0.130
Why?
Surgical Stapling
1
2017
2
0.130
Why?
Renal Artery
1
2017
4
0.130
Why?
Adult
4
2018
3557
0.120
Why?
Laparoscopy
1
2017
95
0.120
Why?
Lung Neoplasms
1
2018
247
0.120
Why?
Postoperative Complications
1
2017
385
0.100
Why?
SEER Program
1
2013
8
0.100
Why?
Hernia, Inguinal
1
2013
15
0.100
Why?
Young Adult
2
2017
863
0.100
Why?
Melanoma
1
2013
34
0.100
Why?
Kidney
1
2013
87
0.090
Why?
Survival Rate
1
2012
152
0.090
Why?
Retrospective Studies
3
2018
1467
0.090
Why?
Rectal Neoplasms
1
2010
6
0.080
Why?
Pyrimidines
1
2010
16
0.080
Why?
Gastrointestinal Stromal Tumors
1
2010
13
0.080
Why?
Piperazines
1
2010
41
0.080
Why?
Female
4
2018
6974
0.080
Why?
Antineoplastic Agents
1
2010
99
0.070
Why?
Tomography, X-Ray Computed
3
2018
281
0.070
Why?
Time Factors
1
2010
695
0.070
Why?
Comorbidity
2
2013
209
0.070
Why?
Incidence
2
2018
338
0.050
Why?
Sensitivity and Specificity
1
2005
252
0.050
Why?
Androgen Antagonists
1
2003
3
0.050
Why?
Prostate-Specific Antigen
1
2003
5
0.050
Why?
Follow-Up Studies
2
2018
726
0.050
Why?
Gene Expression Regulation, Neoplastic
1
2003
60
0.050
Why?
Diagnosis, Differential
1
2003
151
0.050
Why?
Antibodies, Monoclonal
1
2003
86
0.050
Why?
Aged, 80 and over
2
2018
2152
0.050
Why?
Education
1
2019
16
0.040
Why?
Simulation Training
1
2019
15
0.040
Why?
False Positive Reactions
1
2018
23
0.030
Why?
Postoperative Period
1
2018
118
0.030
Why?
Lung
1
2018
76
0.030
Why?
Neoplasm Staging
1
2018
168
0.030
Why?
Practice Guidelines as Topic
1
2018
116
0.030
Why?
Ligation
1
2017
19
0.030
Why?
Arteriovenous Fistula
1
2017
8
0.030
Why?
Operative Time
1
2017
38
0.030
Why?
Linear Models
1
2013
115
0.020
Why?
Multivariate Analysis
1
2013
141
0.020
Why?
Proportional Hazards Models
1
2013
161
0.020
Why?
Treatment Outcome
1
2017
1478
0.020
Why?
Risk Assessment
1
2013
295
0.020
Why?
Imatinib Mesylate
1
2010
4
0.020
Why?
Benzamides
1
2010
8
0.020
Why?
Colectomy
1
2010
10
0.020
Why?
Neoadjuvant Therapy
1
2010
23
0.020
Why?
Biopsy
1
2010
97
0.020
Why?
Risk Factors
1
2013
1049
0.020
Why?
Coogan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (84)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_